Stock listing

A1J1BH Stock Price, News, Filings & Events — Sarepta Therapeutics, Inc.

Selected listing: A1J1BH · LSX · EUR · DE

A1J1BH:LSX represents Sarepta Therapeutics, Inc., a U.S.-based company dedicated to developing innovative therapies for rare genetic disorders. With a market capitalization of around €1.82 billion, Sarepta is focused on addressing serious unmet medical needs through its research and development efforts. The company continues to advance its pipeline of therapies, contributing to the evolving landscape of treatment options for patients. Recent news and filings highlight Sarepta's ongoing commitment to bringing new solutions to market.

A1J1BH:LSXEURDEUpdated July 24, 2026
Sarepta Therapeutics, Inc. logo
Ticker
A1J1BH:LSX
Asset type
Stock
Market cap
$1.66B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
LSX
Currency
EUR

Sarepta Therapeutics, Inc. A1J1BH:LSX stock context

A1J1BH:LSX represents Sarepta Therapeutics, Inc., a U.S.-based company dedicated to developing innovative therapies for rare genetic disorders. With a market capitalization of around €1.82 billion, Sarepta is focused on addressing serious unmet medical needs through its research and development efforts. The company continues to advance its pipeline of therapies, contributing to the evolving landscape of treatment options for patients. Recent news and filings highlight Sarepta's ongoing commitment to bringing new solutions to market.

Research Sarepta Therapeutics, Inc.

Alternate listings